Andrew E Briglia, DO | |
104 Forbes St Ste 102, Annapolis, MD 21401-1543 | |
(410) 571-8333 | |
(410) 573-8338 |
Full Name | Andrew E Briglia |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 31 Years |
Location | 104 Forbes St Ste 102, Annapolis, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063470235 | NPI | - | NPPES |
322801100 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | H53429 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bma - South Annapolis | Annapolis, MD | Dialysis facility |
Fmc - Anne Arundel | Annapolis, MD | Dialysis facility |
Renal Care Of Bowie, Llc | Bowie, MD | Dialysis facility |
Davita-annapolis Dialysis | Annapolis, MD | Dialysis facility |
Anne Arundel Medical Center | Annapolis, MD | Hospital |
Umd Shore Medical Center At Easton | Easton, MD | Hospital |
Entity Name | Annapolis Nephrology Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1356982599 PECOS PAC ID: 4789918251 Enrollment ID: O20200123000134 |
News Archive
FamilyCord, a subsidiary of California Cryobank, is leading the charge in the private cord blood banking industry for safer, more effective collection kits. FamilyCord's start-of-the-art collection kit is redefining the scientific standards for collection and transport employed by the cord blood banking industry.
DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced that yesterday it presented positive preclinical data demonstrating the promising potential of its lead product candidate VAL-083 (dianhydrogalactitol) as a treatment for ovarian cancer.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reports a financial update as of June 30, 2010. In addition, the Company provides a progress update of its MARINE and ANCHOR trials, the two on-going Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.
It was a memorable place to have an "aha" moment about aging. Peter Sperry had taken his 82-year-old father, who'd had a stroke and used a wheelchair, to Disney World. Just after they'd made their way through the Pirates of the Caribbean ride, nature called. Sperry took his father to the bathroom where, with difficulty, he changed the older man's diaper.
Chemicals used in certain pesticides and as insulating material banned in the 1970s may still be haunting us, according to new research that suggests links between higher levels of exposure during pregnancy and significantly increased odds of autism spectrum disorder in children.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Andrew E Briglia, DO Po Box 64152, Baltimore, MD 21264-4152 Ph: (443) 481-6483 | Andrew E Briglia, DO 104 Forbes St Ste 102, Annapolis, MD 21401-1543 Ph: (410) 571-8333 |
News Archive
FamilyCord, a subsidiary of California Cryobank, is leading the charge in the private cord blood banking industry for safer, more effective collection kits. FamilyCord's start-of-the-art collection kit is redefining the scientific standards for collection and transport employed by the cord blood banking industry.
DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced that yesterday it presented positive preclinical data demonstrating the promising potential of its lead product candidate VAL-083 (dianhydrogalactitol) as a treatment for ovarian cancer.
Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reports a financial update as of June 30, 2010. In addition, the Company provides a progress update of its MARINE and ANCHOR trials, the two on-going Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.
It was a memorable place to have an "aha" moment about aging. Peter Sperry had taken his 82-year-old father, who'd had a stroke and used a wheelchair, to Disney World. Just after they'd made their way through the Pirates of the Caribbean ride, nature called. Sperry took his father to the bathroom where, with difficulty, he changed the older man's diaper.
Chemicals used in certain pesticides and as insulating material banned in the 1970s may still be haunting us, according to new research that suggests links between higher levels of exposure during pregnancy and significantly increased odds of autism spectrum disorder in children.
› Verified 7 days ago
Gashaw Adugna Dadi, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 240-495-4189 | |
Dr. Eugene Thomas Manion, MD Nephrology Medicare: Medicare Enrolled Practice Location: 900 Bestgate Road, Suite 303, Annapolis, MD 21401 Phone: 410-224-8220 Fax: 410-841-2482 | |
Dr. Lisa A Dimarzio, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Parkway, Suite 100, Annapolis, MD 21401 Phone: 410-573-1110 Fax: 410-266-0714 | |
Dr. Richard A Bernstein, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 133 Defense Hwy, Suite 109, Annapolis, MD 21401 Phone: 401-224-5558 Fax: 410-224-7321 | |
Dr. Jonathan A Altschuler, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Ste 500, Annapolis, MD 21401 Phone: 410-573-6480 Fax: 410-573-9413 | |
Dr. Ira M Weinstein, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 607, Annapolis, MD 21401 Phone: 410-266-1644 Fax: 410-266-1642 | |
Dr. James M Blake, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 820 Bestgate Road, Suite 2a, Annapolis, MD 21401 Phone: 410-224-2116 Fax: 410-224-2118 |